Ascentage Pharma Group International (AAPG) Other Non-Current Assets (2022 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Ascentage Pharma Group International (AAPG) has disclosed Other Non-Current Assets for 4 consecutive years, with $4.3 million as the latest value for Q4 2025.

• For Q4 2025, Other Non-Current Assets rose 26.32% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, up 26.32%, while the annual FY2025 figure was $4.4 million, 45.92% down from the prior year.
• Other Non-Current Assets hit $4.3 million in Q4 2025 for Ascentage Pharma Group International, up from $3.4 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.3 million in Q4 2025 and bottomed at $2.3 million in Q4 2022.
• Average Other Non-Current Assets over 4 years is $3.4 million, with a median of $3.4 million recorded in 2023.
• Year-over-year, Other Non-Current Assets skyrocketed 46.0% in 2023 and then grew 0.63% in 2024.
• Ascentage Pharma Group International's Other Non-Current Assets stood at $2.3 million in 2022, then surged by 46.0% to $3.4 million in 2023, then grew by 0.63% to $3.4 million in 2024, then rose by 26.32% to $4.3 million in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods came in at $4.3 million, $3.4 million, and $3.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison